Oregon regulators announced on April 18 that they have approved the nation’s first state-licensed psilocybin facilitators to administer the psychedelic to adults at regulated facilities.
Oregon is gearing up for the first legal U.S. psilocybin journeys outside of medical trials later this year: The state just licensed its first legal growers and facilitators, who graduated from approved training programs.
Naloxone is a life-saving drug that rapidly reverses or blocks the effects of opioids, restoring normal respiration, especially when given within minutes of the first signs of an overdose. Narcan is now the first naloxone-based drug available without a prescription.
Scientists at the Texas A&M University have identified a specific circuit in the brain from which many negative emotional states stem from during fentanyl withdrawal and could be the reason many chronic users relapse.
Unlike for most other medical benefits, veterans do not have to be enrolled in the VA system to be eligible. More than 18 million veterans in the U.S. could be eligible.
MDMA and psilocybin will be available for controlled use to address PTSD and depression when prescribed by a psychiatrist starting in July 2023.
In a study published in Pharmaceutics, scientists tested their vaccine on 60 rats. The immunized animals could produce antibodies that stop the deadly drug’s effects.
In tests performed on rats at the University of Houston, the vaccine was shown to be effective at keeping one of the deadliest street drugs from reaching the brain, while not producing any significant side effects.
The measure creates a regulatory framework for psychedelic clinics to operate in the state and completely decriminalizes personal use and possession of several natural hallucinogenic plants.
The age-adjusted prevalence of dementia declined from 12.2 percent of people over age 65 in 2000 to 8.5 percent of people over age 65 in 2016—a nearly one-third drop from the 2000 level, according to a new RAND Corporation study.
